FIGURE 2.

Network of eligible comparisons for all-cause mortality, adverse events and serious adverse events. The figure plots the network of eligible direct comparisons for all-cause mortality (42 studies) (A), adverse events (30 studies) (B) and serious adverse events (30 studies) (C). The width of the lines is proportional to the number of trials comparing every pair of treatments, and the size of every node is proportional to the number of randomized participants.